ArticleOphthalmology. Retina2021

Re: Bontzos et al.: Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study (Ophthalmol Retina. 2020;4:1138-1145).

No numbers read from the abstract.

Not cited yet